OxTalks is Changing
OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Allogeneic hematopoietic cell transplantation recuse monogenic IBD
Prof Hirokazu Kanegane is a Professor at Tokyo Medical and Dental University, specialising in Child Health and Development. He earned his M.D. from Kanazawa University and his Ph.D. from the Graduate School of Medicine, Kanazawa University. Since 2014, he has been associated with Tokyo Medical and Dental University and is the current president for the Asia Pacific society for immunodeficiencies.
Prof Kanegane’s research spans the fields of Immunology, Internal medicine, Cancer research, XIAP and Lymphoproliferative disorders. His research on Immunology often connects related areas such as Hemophagocytic lymphohistiocytosis. The Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology.
Date:
22 October 2024, 12:00
Venue:
John Radcliffe Academic, Headington OX3 9DU
Venue Details:
George Pickering Ed Cen: Seminar Room 4B
Speaker:
Professor Hirokazu Kanegane (Tokyo Medical and Dental University)
Organising department:
Nuffield Department of Clinical Medicine
Organiser:
Professor Holm Uhlig (University of Oxford)
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Sally Pelling-Deeves
